Found 6964 matches for
Circadian Therapeutics, a life sciences spinout of Oxford University, has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
The network is run by a committee of fellows who represent many of our major fellowship programmes. The committee set the direction of the network, organise the workshops, evaluate feedback and help connect our members.
The Industry Fellows and Postdocs Network has been established for just under 3 years and comprises of around 80 postdoctoral researchers and fellows currently working on collaborative programmes with Novo Nordisk, Bristol Myers Squibb (Celgene), UCB, Elysium, Pfizer, Vertex, GSK, Genentech, Astra Zeneca and Janssen.
Our workshops feature speakers from companies who we are in active collaboration with, external providers and Oxford academics working at the interfaces of academic and Industry.
The Health Research Bridging Salary Scheme will provide short-term bridging salary support for early career researchers working in health-related areas who rely on external funding for their salary.
Our Business Partnerships Office (BPO) offer monthly virtual drop-in sessions for medical science researchers, staff and students across the University of Oxford. A member of the BPO team will be available to answer questions relating to forming collaborations with the pharmaceutical / biotech industry, including AI and digital health.